Rediscovering Cancer: From Mechanism to Therapy

Released on by Sayali Mukherjee
preview-18

  • Rediscovering Cancer: From Mechanism to Therapy Book Detail

  • Author : Sayali Mukherjee
  • Release Date : 2018-09-04
  • Publisher : CRC Press
  • Genre : Medical
  • Pages : 599
  • ISBN 13 : 1351166549
  • File Size : 41,41 MB
DOWNLOAD BOOK

Rediscovering Cancer: From Mechanism to Therapy by Sayali Mukherjee PDF Summary

Book Description: This volume presents a snapshot of some of the most important ongoing research in cancer. With cancer as the second leading cause of death worldwide, extensive research is going on globally to decipher the molecular mechanism underlying cancer that will help in finding better targets for drug therapy. The book brings together new research on molecular mechanism and cancer therapeutics in one place. With chapters from experts in their respective fields, chapters cover molecular mechanisms, etiology, prognosis, detection, and treatment of cancer. Emphasis has been given to the intricate mechanism behind the deregulation of cell division, disruption of cell cycle check points, mutation in oncogenes and tumor suppressor genes, apoptosis, and erratic cell signaling. The book discusses in detail topics such as angiogenesis and tumor microenvironment, which are increasingly receiving attention, especially in the field of neoplastic vascularization and metastasis. The book also includes chapters detailing the current understanding and the future perspective of cancer stem cells.

Disclaimer: www.yourbookbest.com does not own Rediscovering Cancer: From Mechanism to Therapy books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Antiangiogenic Agents in Cancer Therapy

Antiangiogenic Agents in Cancer Therapy

File Size : 34,34 MB
Total View : 2114 Views
DOWNLOAD

Beverly Teicher and a panel of distinguished investigators survey the state-of-the-art of antiangiogenesis research from the lab bench to clinical trials. Timel